EP4 receptor antagonists

Compounds of formula (I): wherein: R is H or an optionally substituted C1-4 alkyl group; Y is either -(CH2)n-X-, where n is 1 or 2 and X is O, S, S(=O), S(=O)2, or NR, where R1 is selected from H or optionally substituted C1-4 alkyl, or Y is -C(=O)NR-, where R is selected from H, and optionally subs...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	DAVID EDWARD CLARK, CHRISTOPER GREGORY NEWTON, NEIL VICTOR HARRIS, ALEXANDER WILLIAM OXFORD, GEORGE HYND, ROBERT ALEXANDER COLEMAN, RICHARD JON DAVIS, GARRY FENTON, KENNETH LYLE CLARK, JONATHAN MARK SUTTON, KEITH ALFRED JAMES STUTTLE
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!